MarketPulse

spinoff

7 articles
The Motley FoolThe Motley Fool··Lee Samaha

GE Vernova Overtakes Aerospace Unit as AI Data Center Boom Reshapes Conglomerate

GE Vernova surpasses GE Aerospace in market cap for first time, driven by explosive AI data center demand for its gas turbines and surging orders.
BABApAGEGEVFTAI+3GE VernovaAI data centers
BenzingaBenzinga··Bamboo Works

Kailera's 63% IPO Surge Validates Chinese Pharma 'NewCo' Spinoff Strategy

Kailera Therapeutics surged 63% on Nasdaq debut as weight-loss drug spinoff from Hengrui Pharma, raising $625M and validating the 'NewCo' model for Chinese pharmaceutical companies.
LLYNVOGILDJHPCYKLRAIPOGLP-1 drugs
BenzingaBenzinga··Akanksha Bakshi

FedEx Freight Unveils Growth Roadmap as June 2026 Spinoff Looms

FedEx Freight unveiled growth targets of 4-6% revenue and 10-12% operating income growth ahead of June 2026 spinoff, projecting $1B+ free cash flow annually.
FDXcapital allocationInvestor Day
Investing.comInvesting.com··Leo Miller

Honeywell Spinoff Taps Nuclear, AI Chip Booms but Valuation Raises Red Flags

Solstice Advanced Materials, spun from Honeywell, surges 50% on nuclear and AI chip tailwinds but faces valuation concerns with only 3-4% revenue growth.
TSMINTCHONSOLSnuclear energysupply chain
The Motley FoolThe Motley Fool··David Jagielski, Cpa

SanDisk Stock Up 1,200% Post-Spinoff: Can Momentum Sustain?

SanDisk surged 1,200% post-spinoff, but consensus analyst target implies 23% downside, signaling lofty valuations may have already captured growth expectations.
SNDKWDCstock valuationmemory storage
The Motley FoolThe Motley Fool··Selena Maranjian

Medtronic Strengthens Market Position With Hugo Robotics Entry and Diabetes Spinoff

Medtronic gains FDA approval for Hugo robotic surgery system and spins off diabetes division, strengthening market position while reporting 8.7% revenue growth and maintaining 48-year dividend streak.
MDTISRGFDA approvaldividend growth
BenzingaBenzinga··Vandana Singh

J&J Pursues Strategic Divestiture of DePuy Synthes Orthopedics Unit

J&J plans to divest DePuy Synthes orthopedics unit valued at $20-28 billion. Private equity firms are negotiating potential acquisition bids as part of J&J's portfolio restructuring strategy.
JNJprivate equityearnings beat